SE8700466L - Vacciner mor melanom - Google Patents
Vacciner mor melanomInfo
- Publication number
- SE8700466L SE8700466L SE8700466A SE8700466A SE8700466L SE 8700466 L SE8700466 L SE 8700466L SE 8700466 A SE8700466 A SE 8700466A SE 8700466 A SE8700466 A SE 8700466A SE 8700466 L SE8700466 L SE 8700466L
- Authority
- SE
- Sweden
- Prior art keywords
- peptides
- proteins
- melanom
- vaccines
- mother
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 201000001441 melanoma Diseases 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 102000000440 Melanoma-associated antigen Human genes 0.000 abstract 1
- 108050008953 Melanoma-associated antigen Proteins 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000010189 synthetic method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00119—Melanoma antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82731386A | 1986-02-07 | 1986-02-07 | |
| US07/007,230 US5262177A (en) | 1986-02-07 | 1987-01-27 | Recombinant viruses encoding the human melanoma-associated antigen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8700466D0 SE8700466D0 (sv) | 1987-02-06 |
| SE8700466L true SE8700466L (sv) | 1987-08-08 |
| SE506024C2 SE506024C2 (sv) | 1997-11-03 |
Family
ID=26676698
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8700466A SE506024C2 (sv) | 1986-02-07 | 1987-02-06 | Melanomassocierat P97 antigen och immunogen komposition |
| SE9202934A SE9202934D0 (sv) | 1986-02-07 | 1992-10-07 | Vacciner mot melanom |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9202934A SE9202934D0 (sv) | 1986-02-07 | 1992-10-07 | Vacciner mot melanom |
Country Status (18)
| Country | Link |
|---|---|
| JP (3) | JP2664673B2 (sv) |
| BE (1) | BE1000175A3 (sv) |
| CH (1) | CH675424A5 (sv) |
| DE (1) | DE3703702C2 (sv) |
| DK (1) | DK63287A (sv) |
| ES (2) | ES2012815A6 (sv) |
| FI (1) | FI94836C (sv) |
| GR (1) | GR870195B (sv) |
| HU (1) | HU209144B (sv) |
| IE (1) | IE59597B1 (sv) |
| IT (1) | IT1222359B (sv) |
| MX (1) | MX9203574A (sv) |
| NL (1) | NL8700285A (sv) |
| NO (1) | NO178931C (sv) |
| NZ (1) | NZ219192A (sv) |
| OA (1) | OA08478A (sv) |
| PT (1) | PT84255B (sv) |
| SE (2) | SE506024C2 (sv) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19821925A1 (de) * | 1998-05-15 | 1999-11-18 | Roehnisch Tim | Verfahren zur Herstellung einer Zusammensetzung zur Induktion einer tumorspezifischen Immunantwort, sowie Verwendung der Zusammensetzung zur Behandlung von Neoplasien |
| JP4414023B2 (ja) * | 1999-08-05 | 2010-02-10 | オリエンタル酵母工業株式会社 | 関節炎関連メラノトランスフェリンの測定方法および試薬 |
| JP4708027B2 (ja) * | 2002-10-01 | 2011-06-22 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | 抗癌組成物および抗感染疾患組成物ならびにこれらを使用する方法 |
| US8207314B2 (en) * | 2003-05-16 | 2012-06-26 | Sanofi Pasteur Limited | Tumor antigens for prevention and/or treatment of cancer |
-
1987
- 1987-02-05 NZ NZ219192A patent/NZ219192A/xx unknown
- 1987-02-06 IT IT19291/87A patent/IT1222359B/it active
- 1987-02-06 GR GR870195A patent/GR870195B/el unknown
- 1987-02-06 FI FI870501A patent/FI94836C/sv not_active IP Right Cessation
- 1987-02-06 ES ES8700288A patent/ES2012815A6/es not_active Expired - Fee Related
- 1987-02-06 DK DK063287A patent/DK63287A/da not_active Application Discontinuation
- 1987-02-06 NO NO870475A patent/NO178931C/no unknown
- 1987-02-06 BE BE8700094A patent/BE1000175A3/fr not_active IP Right Cessation
- 1987-02-06 DE DE3703702A patent/DE3703702C2/de not_active Expired - Fee Related
- 1987-02-06 SE SE8700466A patent/SE506024C2/sv not_active IP Right Cessation
- 1987-02-06 IE IE31987A patent/IE59597B1/en not_active IP Right Cessation
- 1987-02-06 NL NL8700285A patent/NL8700285A/nl not_active Application Discontinuation
- 1987-02-06 OA OA59065A patent/OA08478A/xx unknown
- 1987-02-06 JP JP62026191A patent/JP2664673B2/ja not_active Expired - Lifetime
- 1987-02-06 HU HU87472A patent/HU209144B/hu not_active IP Right Cessation
- 1987-02-06 PT PT84255A patent/PT84255B/pt not_active IP Right Cessation
- 1987-02-09 CH CH471/87A patent/CH675424A5/de not_active IP Right Cessation
-
1989
- 1989-06-15 ES ES8902106A patent/ES2017258A6/es not_active Expired - Fee Related
-
1992
- 1992-06-26 MX MX9203574A patent/MX9203574A/es not_active Application Discontinuation
- 1992-10-07 SE SE9202934A patent/SE9202934D0/sv unknown
-
1996
- 1996-03-12 JP JP8054929A patent/JPH08280390A/ja active Pending
- 1996-03-12 JP JP8054928A patent/JPH09135692A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FI870501A (sv) | 1987-08-08 |
| IE59597B1 (en) | 1994-03-09 |
| SE8700466D0 (sv) | 1987-02-06 |
| HUT43107A (en) | 1987-09-28 |
| HU209144B (en) | 1994-03-28 |
| DK63287A (da) | 1987-08-08 |
| FI94836B (sv) | 1995-07-31 |
| IE870319L (en) | 1987-08-07 |
| JP2664673B2 (ja) | 1997-10-15 |
| IT8719291A0 (it) | 1987-02-06 |
| NZ219192A (en) | 1991-10-25 |
| DK63287D0 (da) | 1987-02-06 |
| GR870195B (en) | 1987-06-10 |
| FI94836C (sv) | 1995-11-10 |
| NO178931C (no) | 1996-07-03 |
| JPH09135692A (ja) | 1997-05-27 |
| NL8700285A (nl) | 1987-09-01 |
| PT84255B (pt) | 1989-11-30 |
| SE506024C2 (sv) | 1997-11-03 |
| BE1000175A3 (fr) | 1988-07-12 |
| DE3703702C2 (de) | 1997-07-10 |
| JPH08280390A (ja) | 1996-10-29 |
| CH675424A5 (en) | 1990-09-28 |
| OA08478A (fr) | 1988-07-29 |
| PT84255A (en) | 1987-03-01 |
| IT1222359B (it) | 1990-09-05 |
| NO178931B (no) | 1996-03-25 |
| NO870475L (no) | 1987-08-10 |
| FI870501A0 (sv) | 1987-02-06 |
| NO870475D0 (no) | 1987-02-06 |
| ES2017258A6 (es) | 1991-01-16 |
| ES2012815A6 (es) | 1990-04-16 |
| JPS62294698A (ja) | 1987-12-22 |
| DE3703702A1 (de) | 1988-02-18 |
| SE9202934D0 (sv) | 1992-10-07 |
| MX9203574A (es) | 1992-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE58906121D1 (de) | Rekombinantes Vaccinia-Virus MVA. | |
| DK0584348T3 (da) | Genetisk vaccine mod immundefektvirusser | |
| DE69333397D1 (de) | Retro-, inverso-, und retro-inverso synthetische peptidanaloge | |
| EE9900343A (et) | Sünteetiline polünukleotiid, immuunvastuste tekitamise meetod, immunogeenne kompositsioon, anti-HIV immuunvastuste indutseerimise meetod, meetod antigeeni tekitava raku indutseerimiseks ja farmatseutiline kompositsioon | |
| NO863803L (no) | Vaksiner og immunoanalyser for ervervet immunsviktsyndrom (aids). | |
| DK84195A (da) | Vaccine til frembringelse af et immunogent respons | |
| FI102382B1 (sv) | Expressionssystem för kimeriska glykoproteiner innehållande immunogeniska fragment av glykoproteiner av människans respiratory syncytial -virus | |
| ATE105334T1 (de) | Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3. | |
| DK0909323T3 (da) | Helicobacter pylori-bakterioferritin | |
| DE3689622T2 (de) | Impfstoffe gegen menschliche respiratorische viren. | |
| EP0236977A3 (en) | Bovine virus diarrhea and hog cholera vaccines | |
| ATE73349T1 (de) | Hepatitisoberflaechenantigenpartikelvakzin. | |
| SE8700466L (sv) | Vacciner mor melanom | |
| AR009365A1 (es) | Vacunas del virus de la fiebre aftosa (fmdv), peptidos, secuencias de adn y el uso de los peptidos en sistemas de deteccion y el uso de la vacuna fmdc para la preparacion de una composicion para inmunizar cerdos y ganado vacuno | |
| KR900701291A (ko) | 혈호균속 인플루엔자용 백신과 진단검사법 | |
| NZ213303A (en) | Plasmodium protein, dna sequence and vaccine | |
| DE69428984D1 (de) | Stimulierung der immunantwort durch virales protein | |
| DE60239753D1 (de) | Impfstoff gegen infektiöses lachsanämievirus | |
| DE69637435D1 (de) | Saponin-zusammensetzungen und deren verwendung | |
| BR9306187A (pt) | Vacina bacterin-toxóide pasteurella haemolytica tipo a-1 | |
| AR248047A1 (es) | Procedimiento para la preparacion de una vacuna a base de virus del herpes bovina modificado tipo 1. | |
| ATE332920T1 (de) | Nukleinsäureimpfstoff bestehend aus einem fusionsprotein, dass eine adjuvanssequenz von einem planzenvirushüllprotein aufweist | |
| RU95122782A (ru) | Фармацевтические препараты, содержащие нуклеиновые кислоты | |
| EP0293201A3 (en) | Method of vaccination for hepatitis b virus | |
| RU92004487A (ru) | Днк, полипептид, вакцина, вектор, микроорганизм, клетка насекомого, реагент, способы лечения и профилактики, способ обнаружения антигенов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 8700466-9 Format of ref document f/p: F |